Market Cap | 21.84M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -13.25M | Forward P/E | -2.61 | EPS next Y | 26.80% | 50D Avg Chg | -14.00% |
Sales | 59.32k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -26.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -55.00% |
Recommedations | 3.00 | Quick Ratio | 0.00 | Shares Outstanding | 3.37M | 52W Low Chg | 20.00% |
Insider Own | 48.74% | ROA | -1,261.20% | Shares Float | 1.82M | Beta | 0.27 |
Inst Own | 0.06% | ROE | - | Shares Shorted/Prior | 35.47K/12.81K | Price | 2.09 |
Gross Margin | 35.00% | Profit Margin | - | Avg. Volume | 8,961 | Target Price | 12.00 |
Oper. Margin | -21,871.90% | Earnings Date | Nov 11 | Volume | 566 | Change | 6.63% |
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
Maxim Group | Hold | Jun 4, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
STROME MARK E | 10% Owner 10% Owner | Jun 02 | Buy | 4.99 | 40,000 | 199,600 | 203,601 | 10/30/23 |
Maggiore Christopher D. | Director Director | Sep 14 | Buy | 3.54 | 7,200 | 25,488 | 723,282 | 02/14/23 |
Masterson Nola E | Director Director | Dec 19 | Buy | 2.64 | 300 | 792 | 5,198 | 12/21/22 |
Maggiore Christopher D. | Director Director | Feb 09 | Buy | 3.68 | 91,334 | 336,109 | 803,105 | 02/16/22 |
PAYNE JOHN BERNARD | Director Director | Jan 25 | Buy | 2.5 | 9,168 | 22,920 | 9,344 | 01/28/22 |
Maggiore Christopher D. | Director Director | Jan 11 | Buy | 2.6397 | 7,560 | 19,956 | 711,771 | 01/14/22 |
Maggiore Christopher D. | Director Director | Dec 01 | Option | 0.1 | 250,000 | 25,000 | 40,954,122 | 12/01/20 |
RICE II PHILIP M | Chief Financial Offi.. Chief Financial Officer | Dec 01 | Option | 0.1 | 250,000 | 25,000 | 250,000 | 12/01/20 |
Masterson Nola E | Director Director | Dec 01 | Option | 0.1 | 250,000 | 25,000 | 568,182 | 12/01/20 |